Rituximab combined to ACVBP (R-ACVBP) as a new inductive treatment followed by high-dose consolidative autotransplantation (HDC) for poor risk diffuse large B-cell lymphoma (DLBCL) in first-line.: Preliminary results on 119 patients of a GELA phase II study.

被引：2
|
作者：
Belhadi, Karim
Fitoussi, Olivier
Haioun, Corinne
Mounier, Nicolas
Lederlin, Pierre
Coiffier, Bertrand
Recher, Christian
Casasnovas, Olivier
Sebban, Catherine
Ferme, Christophe
Tilly, Herve
Gisselbrecht, Christian
机构：
[1] Hop Henri Mondor, Serv Hematol, F-94010 Creteil, France
[2] Polyclin Bordeuax Nord, Serv Oncol, Bordeaux, France
[3] Hop St Louis, Inst Hematol, Paris, France
[4] CHU Nancy Brabois, Serv Hematol, Vandoeuvre Les Nancy, France
[5] CHU Purpan, Serv Hematol, Toulouse, France
[6] CHU Dijon, Serv Hematol, Dijon, France
[7] Ctr Leon Berard, Serv Hematol, F-69373 Lyon, France
[8] Inst Gustave Roussy, Dept Med, Villejuif, France
[9] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.3049.3049
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3049
引用
收藏
页码：868A / 868A
页数：1
相关论文
共 50 条
  • [1] Rituximab combined to ACVBP (R-ACVBP) supported by pegfilgrastim as a new inductive treatment followed by high-dose consolidative autotransplantation (HDC) for poor risk diffuse large B-cell lymphoma (DLBCL) in first-line. Results of LNH 03-39B. A GELA study
    Belhadj, Karim
    Jais, Jean-Philipp
    Feugier, Pierre
    Gisselbrecht, Christian
    Recher, Christian
    Casasnova, Olivier
    Coiffier, Bertrand
    Sebban, Catherine
    Delmer, Alain
    Morschhauser, Franck
    Canioni, Daniele
    Tilly, Herve
    Haioun, Corinne
    BLOOD, 2007, 110 (11) : 1007A - 1007A
  • [2] Survival Impact of Rituximab Combined to ACVBP (R-ACVBP) in 209 Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) Patients Treated with Upfront High-Dose Consolidative Autotransplantation (HDC) : A GELA Phase II Study
    Gisselbrecht, Christian
    Fitoussi, Olivier
    Belhadj, Karim
    Mounier, Nicolas
    Feugier, Pierre
    Coiffier, Bertrand
    Recher, Christian
    Casasnovas, Olivier
    Sebban, Catherine
    Ferme, Christophe
    Briere, Josette
    Tilly, Herve
    Haioun, Corinne
    BLOOD, 2008, 112 (11) : 286 - 286
  • [3] SURVIVAL IMPACT OF RITUXIMAB COMBINED TO ACVBP (R-ACVBP) IN 209 POOR RISK DLBCL NHL PATIENTS TREATED WITH UPFRONT HIGH-DOSE CONSOLIDATIVE AUTOTRANSPLANTATION (HDC): A GELA PHASE II STUDY
    Fitoussi, O.
    Mounier, N.
    Belhadj, K.
    Tilly, H.
    Haioun, C.
    Casasnovas, O.
    Ferme, C.
    Briere, J.
    Coiffier, B.
    Feugier, P.
    Gisselbrecht, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 396 - 396
  • [4] Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA
    Fitoussi, Olivier
    Belhadj, Karim
    Mounier, Nicolas
    Parrens, Marie
    Tilly, Herve
    Salles, Gilles
    Feugier, Pierre
    Ferme, Christophe
    Ysebaert, Loic
    Gabarre, Jean
    Herbrecht, Raoul
    Janvier, Maud
    Van den Neste, Eric
    Morschhauser, Franck
    Casasnovas, Olivier
    Ghesquieres, Herve
    Anglaret, Bruno
    Brechignac, Sabine
    Haioun, Corinne
    Gisselbrecht, Christian
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08): : 1136 - 1143
  • [5] Benefit of rituximab combined to ACVBP (R-ACVBP) over ACVBP in 209 poor- risk BDLC NHL patients treated with up-front consolidative autotransplantation: A GELA phase II trial (LNH 2003-3)
    Mounier, N.
    Gisselbrecht, C.
    Fitoussi, O.
    Belhadj, K.
    Feugier, P.
    Coiffier, B.
    Tilly, H.
    Casasnovas, O.
    Ferme, C.
    Briere, J.
    Haioun, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] FAVORABLE OUTCOME IN YOUNG PATIENTS WITH NON-GERMINAL CENTRE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-ACVBP AS COMPARED TO R-CHOP. A GELA STUDY
    Molina, T. J.
    Canioni, D.
    Copie-Bergman, C.
    Recher, C.
    Fournier, M.
    Haioun, C.
    Briere, J.
    Berger, F.
    Ferme, C.
    Copin, M.
    Casasnovas, O.
    Thieblemont, C.
    Gaulard, P.
    Coiffier, B.
    Tilly, H.
    ANNALS OF ONCOLOGY, 2011, 22 : 155 - 155
  • [7] Final results of a randomized phase II GELA/LYSA study of rituximab plus ACVBP or CHOP, using a PET-driven consolidation strategy, in patients with high-risk diffuse large B-cell lymphoma (DLBCL).
    Casasnovas, Rene-Olivier
    Ysebaert, Loic
    Thieblemont, Catherine
    Coiffier, Bertrand
    Bologna, Serge
    Lepeu, Gerard
    Delmer, Alain
    Plantier, Isabelle
    Gabarre, Jean
    Andre, Marc
    Senecal, Delphine
    Fruchart, Christophe
    Meignan, Michel
    Berriolo-Riedinger, Alina
    Bardet, Stephane
    Molina, Thierry Jo
    Jais, Jean-Philippe
    Haioun, Corinne
    Tilly, Herve
    Morschhauser, Franck
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] A Prospective Randomized Study Comparing Dose Intensive Immunochemotherapy with R-ACVBP vs Standard R-CHOP In Younger Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Recher, Christian
    Coiffier, Bertrand
    Haioun, Corinne
    Ferme, Christophe
    Molina, Thierry Jo
    Casasnovas, Olivier
    Gisselbrecht, Christian
    Bosly, Andre
    Laurent, Guy
    Morschhauser, Franck
    Ghesquieres, Herve
    Jardin, Fabrice
    Bologna, Serge
    Fruchart, Christophe
    Canioni, Danielle
    Corront, Bernadette
    Gabarre, Jean
    Bonnet, Christophe
    Janvier, Maud
    Tilly, Herve
    BLOOD, 2010, 116 (21) : 53 - 54
  • [9] Rituximab vs observation after high-dose consolidative first-line chemotherapy (HDC) with autologous stem cell transplantation in poor risk diffuse large B-cell lymphoma.: Final analysis of the LNH98-B3 GELA study.
    Haioun, C
    Mounier, N
    Emile, JF
    Feugier, P
    Coiffier, B
    Tilly, H
    Recher, C
    Fermé, C
    Gabarre, J
    Herbrecht, R
    Morschhauser, F
    Gisselbrecht, C
    BLOOD, 2005, 106 (11) : 200A - 200A
  • [10] Rituximab compared to observation after high-dose consolidative first-line chemotherapy (HDC) with autologous stem cell transplantation in poor-risk diffuse large B-cell lymphoma: Updated results of the LNH98-B3 GELA study
    Haioun, C.
    Mounier, N.
    Emile, J. F.
    Bologna, S.
    Coiffier, B.
    Tilly, H.
    Recher, C.
    Ferme, C.
    Morschhauser, F.
    Gisselbrecht, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345